19 January 2015
Prostate cancer drug slows memory loss in women with Alzheimer’s disease
Women with Alzheimer’s disease showed stable cognition for a year when a drug that is more commonly used to treat advanced prostate cancer was added to their drug regimen, according to a new study from researchers at the University of Wisconsin-Madison.
12 January 2015
A virtual reality brain training game can detect mild cognitive impairment, a condition that often predates Alzheimer’s disease
Greek researchers demonstrated the potential of a virtual supermarket cognitive training game as a screening tool for patients with mild cognitive impairment among a sample of older adults.
8 January 2015
Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia
A man-made form of insulin delivered by nasal spray may improve working memory and other mental capabilities in adults with MCI and AD, according to a pilot study led by researchers at Wake Forest Baptist Medical Center.
15 December 2014
Running and Walking May Lower Alzheimer's Disease Risk
An estimated 5 million Americans aged 65 and older have Alzheimer’s disease. As drug companies struggle to find a cure, new research from the National Runners’ and Walkers’ Health Study suggests that exercise earlier in life may substantially reduce Alzheimer’s disease mortality.
1 December 2014
Better Detection, Prevention, and Pre-Clinical Treatment: Three Effective Tools in the Fight Against Alzheimer's Disease
Detection, prevention, and preclinical treatment are three key areas that may make a difference in the battle to reduce the rapid rise of new Alzheimer’s disease cases every year. These three topics are the focus of an important new supplement in JAD.
1 December 2014
New Data Suggest Treatment Effect on Cognition Leads to the Treatment Effect on Function in Patients with Mild Alzheimer’s Disease
Eli Lilly and Company announced results from new analyses of two Phase 3 trials evaluating the relationship between cognitive and functional treatment effects in patients with mild Alzheimer’s disease. Based on post-hoc analyses of the Phase 3 trials, the findings suggested that cognitive deficits were more apparent than functional deficits in mild Alzheimer’s disease. The apparent treatment effect on cognition based on these analyses led to the apparent treatment effect on function.
14 November 2014
Mind before matter: do negative thoughts increase risk of Alzheimer's disease?
Researchers from the Institute of Psychiatry, Psychology & Neuroscience at King’s College London have proposed that repetitive negative thinking, a common symptom of many psychological disorders, may increase the risk of developing Alzheimer’s disease.
21 October 2014
New Research on Walnuts and the Fight Against Alzheimer's Disease
A new animal study published in the Journal of Alzheimer's Disease indicates that a diet including walnuts may have a beneficial effect in reducing the risk, delaying the onset, slowing the progression of, or preventing Alzheimer’s disease.
19 September 2014
People at high risk of Alzheimer's may have early visuomotor difficulties
Before there are any telltale behavioural signs of dementia, a simple test that combines thinking and movement could point to those with a heightened risk of developing Alzheimer’s disease and who are already having visuomotor difficulties, according to new research out of York University.
16 September 2014
UB researchers corroborate the neuroprotective effects of Sirtuin 1 activation on mice with Alzheimer's disease
A study coordinated by the University of Barcelona has described a mechanism that plays a key role in the evolution of Alzheimer’s disease (AD). The activation of the protein Sirtuin 1 in a murine model with familial AD has neuroprotective effects.